These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 12114337)

  • 21. Intranasal fentanyl for initial treatment of vaso-occlusive crisis in sickle cell disease.
    Fein DM; Avner JR; Scharbach K; Manwani D; Khine H
    Pediatr Blood Cancer; 2017 Jun; 64(6):. PubMed ID: 27862905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Mixed-Methods Study of Pain-related Quality of Life in Sickle Cell Vaso-Occlusive Crises.
    Lin RJ; Evans AT; Wakeman K; Unterbrink M
    Hemoglobin; 2015; 39(5):305-9. PubMed ID: 26114739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emergency department analgesia without narcotics for adults with acute sickle cell pain crisis: case reports and review of crisis management.
    Pollack CV; Sanders DY; Severance HW
    J Emerg Med; 1991; 9(6):445-52. PubMed ID: 1787291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Timing of opioid administration as a quality indicator for pain crises in sickle cell disease.
    Mathias MD; McCavit TL
    Pediatrics; 2015 Mar; 135(3):475-82. PubMed ID: 25667245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human platelet alloantigens (HPA) 1, HPA2, HPA3, HPA4, and HPA5 polymorphisms in sickle cell anemia patients with vaso-occlusive crisis.
    Al-Subaie AM; Fawaz NA; Mahdi N; Al-Absi IK; Al-Ola K; Ameen G; Almawi WY
    Eur J Haematol; 2009 Dec; 83(6):579-85. PubMed ID: 19702628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low-Dose Ketamine Infusion for Adjunct Management during Vaso-occlusive Episodes in Adults with Sickle Cell Disease: A Case Series.
    Palm N; Floroff C; Hassig TB; Boylan A; Kanter J
    J Pain Palliat Care Pharmacother; 2018 Mar; 32(1):20-26. PubMed ID: 29791238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Death from a morphine infusion during a sickle cell crisis.
    Gerber N; Apseloff G
    J Pediatr; 1993 Aug; 123(2):322-5. PubMed ID: 8345436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma PTX3 levels in sickle cell disease patients, during vaso occlusion and acute chest syndrome (data from Saudi population).
    Elshazly SA; Heiba NM; Abdelmageed WM
    Hematology; 2014 Jan; 19(1):52-9. PubMed ID: 23735470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. State of the Art Management of Acute Vaso-occlusive Pain in Sickle Cell Disease.
    Puri L; Nottage KA; Hankins JS; Anghelescu DL
    Paediatr Drugs; 2018 Feb; 20(1):29-42. PubMed ID: 28853040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tramadol infusion for the pain management in sickle cell disease: a case report.
    Erhan E; Inal MT; Aydinok Y; Balkan C; Yegul I
    Paediatr Anaesth; 2007 Jan; 17(1):84-6. PubMed ID: 17184440
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of propofol anaesthesia on thoraco-abdominal volume variations during spontaneous breathing and mechanical ventilation.
    Aliverti A; Kostic P; Lo Mauro A; Andersson-Olerud M; Quaranta M; Pedotti A; Hedenstierna G; Frykholm P
    Acta Anaesthesiol Scand; 2011 May; 55(5):588-96. PubMed ID: 21385159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment and prevention of pain due to vaso-occlusive crises in adults with sickle cell disease: an educational void.
    Solomon LR
    Blood; 2008 Feb; 111(3):997-1003. PubMed ID: 17940207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Addressing challenges of clinical trials in acute pain: The Pain Management of Vaso-occlusive Crisis in Children and Young Adults with Sickle Cell Disease Study.
    Nottage KA; Hankins JS; Faughnan LG; James DM; Richardson J; Christensen R; Kang G; Smeltzer M; Cancio MI; Wang WC; Anghelescu DL
    Clin Trials; 2016 Aug; 13(4):409-16. PubMed ID: 27000103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of respiratory inductive plethysmography in the measurement of breathing pattern and PEEP-induced changes in lung volume.
    Valta P; Takala J; Foster R; Weissman C; Kinney JM
    Chest; 1992 Jul; 102(1):234-8. PubMed ID: 1623760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current issues in sickle cell pain and its management.
    Ballas SK
    Hematology Am Soc Hematol Educ Program; 2007; ():97-105. PubMed ID: 18024616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of acute pain crisis on exhaled nitric oxide levels in children with sickle cell disease.
    Pawar SS; Panepinto JA; Brousseau DC
    Pediatr Blood Cancer; 2008 Jan; 50(1):111-3. PubMed ID: 16619223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pain management in adult acute sickle cell pain crisis: a viewpoint.
    Udezue E; Herrera E
    West Afr J Med; 2007; 26(3):179-82. PubMed ID: 18399330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low-dose ketamine as a potential adjuvant therapy for painful vaso-occlusive crises in sickle cell disease.
    Neri CM; Pestieau SR; Darbari DS
    Paediatr Anaesth; 2013 Aug; 23(8):684-9. PubMed ID: 23565738
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of abdominal and thoracic breathing on breathing pattern components in normal subjects and in patients with chronic obstructive pulmonary disease.
    Sackner MA; Gonzalez HF; Jenouri G; Rodriguez M
    Am Rev Respir Dis; 1984 Oct; 130(4):584-7. PubMed ID: 6486557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Emergencies in adults with sickle cell disease].
    Godeau B
    Bull Acad Natl Med; 2004; 188(3):507-15; discussion 515-7. PubMed ID: 15584659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.